Page 51 - Quantitative Imaging of Small Tumours with Positron Emission Tomography
P. 51

                                Chapter 2 22. Sattarivand M, Kusano M, Poon I, Caldwell C. Symmetric geometric transfer matrix partial volume correction for PET imaging: principle, validation and robustness. Phys Med Biol. 2012;57:7101-7116. 23. Sattarivand M, Armstrong J, Szilagyi GM, Kusano M, Poon I, Caldwell C. Region-Based Partial Volume Correction Techniques for PET Imaging: Sinogram Implementation and Robustness. Int J Mol Imaging. 2013;2013:435959. 24. Hofheinz F, Langner J, Petr J, et al. A method for model-free partial volume correction in oncological PET. EJNMMI Res. 2012;2:16. 25. Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med. 2004;45:1519- 1527. 26. Frings V, van Velden FH, Velasquez LM, et al. Repeatability of metabolically active tumor volume measurements with FDG PET/CT in advanced gastrointestinal malignancies: a multicenter study. Radiology. 2014;273:539-548. 27. van Dalen JA, Hoffmann AL, Dicken V, et al. A novel iterative method for lesion delineation and volumetric quantification with FDG PET. Nucl Med Commun. 2007;28:485-493. 28. Kramer GM, Frings V, Hoetjes N, et al. Repeatability of quantitative uptake measures of whole body [18F]FDG PET/CT in NSCLC patients. J Nucl Med. 2015;56(suppl 3):1379. 29. Oprea-Lager DE, Kramer G, van de Ven PM, et al. Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer. J Nucl Med. 2016;57:721-727. 30. Young H, Baum R, Cremerius U, et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer. 1999;35:1773-1782. 31. Shankar LK, Hoffman JM, Bacharach S, et al. Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. J Nucl Med. 2006;47:1059-1066. 32. Boellaard R, Delgado-Bolton R, Oyen WJ, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328-354. 33. Daouk J, Fin L, Bailly P, Meyer ME. Respiratory-gated positron emission tomography and breath- hold computed tomography coupling to reduce the influence of respiratory motion: methodology and feasibility. Acta Radiol. 2009;50:144-155. 50 


































































































   49   50   51   52   53